Salbutamol-Theophylline Interactions: Results of Adding Maximally Effective Doses of Theophylline to the Maximal Effects Obtainable from Salbutamol in Chronic Bronchitis
Abstract:3~measurements of lung function include the larynx as an in-series resistance to airflow it is important to know how the width of glottic chink varies in patients with lung disease. Patients undergoing fibre-optic bronchoscopy were studied; in each, lung function has been assessed by spirometry. From photographs of the vocal cords taken on inspiration and expiration via bronchoscopy, width of the glottic chink was assessed.Photographs were projected over a standard distance on to 1 mm-square graph paper and an… Show more
“…The aim of bronchodilator therapy in patients with chronic bronchitis is to treat any airways obstruction that is reversible. B 2 ‐agonists administered in low doses by inhalation are comparatively poor bronchodilators in this disease, but in higher inhaled doses they may be more effective 6 , 7 . The vagal component of broncho‐constriction appears to be more prominent with increasing age and airflow obstruction 8 , and, when given by inhalation, IPB is an effective bronchodilator in patients with chronic airflow limitation 9 .…”
“…The aim of bronchodilator therapy in patients with chronic bronchitis is to treat any airways obstruction that is reversible. B 2 ‐agonists administered in low doses by inhalation are comparatively poor bronchodilators in this disease, but in higher inhaled doses they may be more effective 6 , 7 . The vagal component of broncho‐constriction appears to be more prominent with increasing age and airflow obstruction 8 , and, when given by inhalation, IPB is an effective bronchodilator in patients with chronic airflow limitation 9 .…”
“…The changes in Rt and IGV were calculated as a percentage of the baseline value. Plethysmographic measurements were performed a t-1 0 .0 , 1,5,10,15,20,30,40,50,60. 90, 120, 180, and 240 min.…”
Section: Methodsmentioning
confidence: 99%
“…[34] described no better bronchodilatation after parenteral administration than after aerosol inhalation of terbutaline. Recommen dations for the dosages of drugs cannot be standardized since the amount required to stabilize the lung function optimally in patients with COAD varies [20,21], In these patients the indiviudal optimal dosage regimen has to be discovered by trial and error [35,36].…”
Section: Relations Between Fenoterol Plasma Concentration and Rtmentioning
As an example of β2-agonists fenoterol was used in this study on 27 patients with chronic obstructive airways diseases (COAD). After refraining from any kind of bronchodilator during 12 h the patients were given the drug in a crossover design in three groups. Using aerosol inhalation, intravenous route and nasal instillation we measured the response of airway resistance, intrathoracic gas volume and fenoterol plasma concentrations. The plethysmographic measurement of airways resistance (Rt) and intrathoracic gas volume showed comparable results of bronchodilation (at different dosages) for each of the routes. Even the onset of action was nearly the same with all the different routes. The amount of bronchodilatation was in the range of 59% of the initial Rt values. The duration of bronchodilatation was much longer after metered dose inhalers (MDI) inhalation ( > 4 h) than after intravenous routes. The duration after nasal administration was in between. The infusion maintains its effect only as long as the infusion is given. The bronchodilation response induced by fenoterol reaches the same values with different routes of administration and depends on the amount of decrease of airway obstruction. The highest plasma concentrations were reached with the intravenous boluses. Immediately after injection the concentration decreased rapidly. The maximum plasma concentrations after MDI were around 20% of that after the intravenous route for the same bronchodilatation. The heart rate is a function of the plasma concentration. At low concentrations such as after aerosol inhalation of 200 µg the influence on the heart rate is not significant. After aerosol inhalation the effect at the receptor can be calculated to be > 7 times stronger than seen from any plasma concentration after intravenous administration. It is assumed that there are structures near the β2-bronchodilator receptor which are responsible for the long-lasting effect that is observed only after aerosol inhalation. These depot structures cannot be reached from the plasma in concentrations needed under in vivo conditions. Loss of these structures shortens the duration of the bronchodilator effect. In respect to effect/side effect relationship, more frequent administration of smaller doses may be the best method for administering β2-agonists as aerosols in patients with COAD. For many patients with severe forms of this disease, individual optimal dosage with MDI has to be defined following repeated measurements of the airway obstruction so as to achieve the best possible bronchodilatation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.